A Retrospective Observation of Treatment Outcomes Using Decitabine-Combined Standard Conditioning Regimens Before Transplantation in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Hypomethylating agents, decitabine (DAC) and azacitidine, can act as prophylactic and pre-emptive approaches after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and a non-intensive bridging approach before allo-HSCT. However, they are rarely used as a part of conditioning regimens i...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yuhang, Cheng, Longcan, Xu, Chen, Chen, Jianlin, Hu, Jiangwei, Liu, Na, Lan, Sanchun, Xie, Jing, Sun, Ting, Wang, Lei, Zhang, Yu, Sun, Yao, Chen, Shuiping, Hu, Liangding
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421765/
https://www.ncbi.nlm.nih.gov/pubmed/34504785
http://dx.doi.org/10.3389/fonc.2021.702239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421765/
https://www.ncbi.nlm.nih.gov/pubmed/34504785
http://dx.doi.org/10.3389/fonc.2021.702239

Ejemplares similares